Search

Search Constraints

You searched for: Author/Creator Rivera, Michele

Search Results

1. Cost-effectiveness of a melanoma screening programme using whole disease modelling. (September 2020)

2. Cost‐effectiveness analysis of the new oncological drug durvalumab in Italian patients with stage III non‐small cell lung cancer. Issue 19 (15th August 2022)

3. Differences in direct costs of patients with stage I cutaneous melanoma: A real-world data analysis. Issue 6 (June 2020)

4. Estimated direct costs of non‐small cell lung cancer by stage at diagnosis and disease management phase: A whole‐disease model. Issue 1 (21st November 2020)